09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

POTASSIUM BROMATE<br />

CAS No: 7758-01-2<br />

I. PHYSICAL AND CHEMICAL PROPERTIES (From HSDB, 1994)<br />

Molecular weight 167.01<br />

Boiling point<br />

not available<br />

Melting point 434 °C<br />

Vapor pressure<br />

not available<br />

Air concentration conversion 1 ppm = 6.8 mg/m 3<br />

II.<br />

HEALTH ASSESSMENT VALUES<br />

Unit Risk Factor: 1.4 E-4 (µg/m 3 ) -1<br />

Slope Factor: 4.9 E-1 (mg/kg-day) -1<br />

[Male rat kidney tumor data (Kurokawa et al., 1983), contained in Gold et al. (1987)<br />

database, expedited Proposition 65 methodology (Cal/EPA, 1992), with cross-route<br />

extrapolation.]<br />

III.<br />

CARCINOGENIC EFFECTS<br />

Human Studies<br />

No studies on the potential carcinogenic effects of potassium bromate in humans are known to exist.<br />

Animal Studies<br />

Male and female Wistar rats (90/sex/group) (Fisher et al., 1979) and “Theiller’s Original” strain mice<br />

(60/sex/group) (Ginocchio et al., 1979) were fed diets consisting of 79% bread crumbs made from<br />

untreated flour, or flour containing 50 mg/kg or 75 mg/kg potassium bromate. Mice and rats were fed<br />

treated diet for 80 and 104 weeks, respectively. No significant increase in tumor induction was<br />

reported; however, IARC (1986) noted that bromates are substantially degraded during bread baking.<br />

Male and female Fischer 344 (F344) rats were exposed to 0, 250 or 500 mg/l potassium bromate in<br />

drinking water for 100 weeks (Kurokawa et al., 1983). Group sizes were 52-53/sex/group. Total<br />

doses were 9.6 and 21.3 mg/kg body weight for low and high dose males, respectively, and 9.6 and<br />

19.6 mg/kg body weight for low and high dose females, respectively. Significant increases in the<br />

incidences of renal andenomas and adenocarcinomas were noted in both males and females; significant<br />

increases were also noted in the incidence of peritoneal mesotheliomas in males, and of thyroid tumors<br />

in females. Tumor incidence data is listed in Table 1.<br />

497

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!